RHOH
Rho-related GTP-binding protein RhoH
Also known as: ARHH, RHOH_HUMAN, TTF
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15669
- Gene
- RHOH
- Ensembl
- ENSG00000168421
- Chromosome
- 4
- Canonical length
- 191 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Golgi apparatus,Vesicles
OverviewNCBI Gene
The protein encoded by this gene is a member of the Ras superfamily of guanosine triphosphate (GTP)-metabolizing enzymes. The encoded protein is expressed in hematopoietic cells, where it functions as a negative regulator of cell growth and survival. This gene may be hypermutated or misexpressed in leukemias and lymphomas. Chromosomal translocations in non-Hodgkin's lymphoma occur between this locus and B-cell CLL/lymphoma 6 (BCL6) on chromosome 3, leading to the production of fusion transcripts. Alternative splicing in the 5' untranslated region results in multiple transcript variants that encode the same protein. [provided by RefSeq, May 2013]
Canonical amino-acid sequenceUniProt
191 residues, UniProt reviewed canonical sequence.
>Q15669|RHOH
1 MLSSIKCVLV GDSAVGKTSL LVRFTSETFP EAYKPTVYEN TGVDVFMDGI QISLGLWDTA
61 GNDAFRSIRP LSYQQADVVL MCYSVANHNS FLNLKNKWIG EIRSNLPCTP VLVVATQTDQ
121 REMGPHRASC VNAMEGKKLA QDVRAKGYLE CSALSNRGVQ QVFECAVRTA VNQARRRNRR
181 RLFSINECKI FLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RHOH can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 99 nTPM
Expression across tissuesHPA
Tissue
- thymus: 99 nTPM
- lymph node: 92 nTPM
- tonsil: 86 nTPM
- bone marrow: 70 nTPM
- appendix: 39 nTPM
- spleen: 34 nTPM
Single-cell type
- mast cells: 1,000 nCPM
- b-cells: 771 nCPM
- plasma cells: 723 nCPM
- t-cells: 643 nCPM
- thymocytes: 379 nCPM
- nk-cells: 359 nCPM
Immune cell
- naive CD4 T-cell: 308 nTPM
- T-reg: 296 nTPM
- naive CD8 T-cell: 253 nTPM
- naive B-cell: 239 nTPM
- basophil: 231 nTPM
- memory CD4 T-cell: 201 nTPM
Brain region
- midbrain: 4.3 nTPM
- white matter: 3.9 nTPM
- medulla oblongata: 3.8 nTPM
- spinal cord: 3.5 nTPM
- pons: 3.4 nTPM
- hypothalamus: 3.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RHOH.
Disease | AllUniProt
Conditions RHOH is implicated in, by any mechanism.
- Immunodeficiency 129 (IMD129) MIM:618307
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.06
- gnomAD pLI
- 0.15
- gnomAD missense Z
- 1.67
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin filament organization
- mast cell activation
- negative regulation of canonical NF-kappaB signal transduction
- positive regulation of T cell differentiation
- regulation of DNA-templated transcription
- signal transduction
- small GTPase-mediated signal transduction
- T cell differentiation
Molecular functions
- GTP binding
- GTPase activity
- GTPase inhibitor activity
- kinase inhibitor activity
- protein kinase binding
- small GTPase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RHOH in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RHOH as an antibody target. Whether an autoantibody or antibody against RHOH could matter depends on whether native RHOH is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RHOH is annotated at the cell surface, where native RHOH is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label RHOH as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...